Stocks · Health care · Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Clue Score32
United States Fiscal year ends December CIK 0001061983 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Robert I Blum
17 Mar 2026
President & CEO
Sell
23,928
$62.15
$1.49M
Robert I Blum
17 Mar 2026
President & CEO
Sell
12,673
$62.15
$787.63K
Fady Ibraham Malik
17 Mar 2026
EVP Research & Development
Sell
4,397
$62.15
$273.27K
Fady Ibraham Malik
17 Mar 2026
EVP Research & Development
Sell
7,636
$62.15
$474.58K
Andrew Callos
17 Mar 2026
EVP, Chief Commercial Officer
Sell
2,916
$62.15
$181.23K
Andrew Callos
17 Mar 2026
EVP, Chief Commercial Officer
Sell
5,626
$62.15
$349.66K
Sung Lee
17 Mar 2026
EVP, Chief Financial Officer
Sell
4,935
$62.15
$306.71K
Robert I Blum
9 Mar 2026
President & CEO
Sell
7,931
$60.72
$481.57K
Fady Ibraham Malik
9 Mar 2026
EVP Research & Development
Sell
2,907
$60.72
$176.51K
Andrew Callos
9 Mar 2026
EVP, Chief Commercial Officer
Sell
2,582
$60.72
$156.78K

What was left out

Form 4 filings counted 125
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 22
Sales straight out of an exercise 53
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 1,087,174
History held since 3 Oct 2006